© 2022 MJH Life Sciences and Medical Economics. All rights reserved.
© 2022 MJH Life Sciences™ and Medical Economics. All rights reserved.
An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Takeaways of the REDUCE-IT trial of icosapent ethyl as treatment for dyslipidemia and hypertriglyceridemia.
The role of ezetimibe and PCSK9 inhibitors as treatment for patients who are statin intolerant or require add-on therapy to help reduce cholesterol levels.
What to know about the efficacy of statin therapies used as cholesterol-lowering therapy.
The standard of care for managing high cholesterol levels.
The value of interdisciplinary research and multidisciplinary care of patients at high risk for cardiovascular events.